Opiant Pharmaceuticals Inc
Biotechnology
Healthcare
OPNT
5.09 M shares
NASDAQ US
traded
01 Mar 2023
listed
yes
open
20.88
52 week high
31.74
high
20.94
52 week low
9.38
low
20.56
growth
-20.15 %
previous Close
20.77
P/E ratio
-9
market cap
66.15 M
div yield
0
usd
Jul 2022
qoq
revenue
3.89 M
87.00 %
net incoming
-11.74 M
-96.00 %
eps
-2.31 %
4.94 %
eps surprise
-69.85 %
net profit margin
-301.38 %
-28.00 %
operating incoming
-11.37 M
-96.00 %
net change in cash
-8.15 M
-177.85 %
cash on hand
40.17 M
-16.87 %
cost of revenue
0.00 %
top top